Trusted Resources: Community Center
A Guide to Understanding MPS IV
MPS IV is a mucopolysaccharide disease known as Morquio or Morquio-Brailsford syndrome. MPS IV takes its name from Dr. Morquio, a pediatrician in Montevideo, Uruguay, who in 1929 described a family of four children affected by this condition.
As the same condition was also described in the same year by Dr. Brailsford from Birmingham, England, it is sometimes known as Morquio-Brailsford syndrome. MPS IV has a wide range of symptoms that vary in severity and can be managed and treated with enzyme replacement therapies. There is no cure for MPS IV.
BookmarkRelated Content
-
Airway Management of the Deformed Trachea Using T-Tube Stents in Patients With Mucopolysaccharidosis Type IVAIntroduction: Mucopolysaccharidosis (MPS...
-
The Youngest Pair of Siblings With Mucopolysaccharidosis Type IVA to Receive Enzyme Replacement Therapy to Date: A C...Mucopolysaccharidosis type IVA (OMIM 253...
-
Disease Burden, Management Patterns and Multidisciplinary Clinical Approaches for Patients With MPS IVA and VI in Se...There is a paucity of real-world epidemi...
-
Steve HollandSteve Holland, CPA is the proud father o...
-
Plasma Proteomic Analysis in Morquio A DiseaseMucopolysaccharidosis type IVA (MPS IVA)...
-
Raleigh Run for RareThe National MPS Society will host a tim...
-
Mucopolysaccharidosis Type VI – An Updated Overview of the DiseaseMucopolysaccharidosis type VI, or Marote...
